Orthopediatrics (KIDS) Cash & Current Investments (2016 - 2026)
Orthopediatrics (KIDS) posted quarterly Cash & Current Investments of $14.2 million for Q1 2026, down 75.76% year-over-year from $58.8 million in Q1 2025, and down 76.59% quarter-over-quarter from $60.9 million in Q4 2025.
Orthopediatrics (KIDS) Cash & Current Investments (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has reported Cash & Current Investments for 11 consecutive years, with $14.2 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 75.76% year-over-year to $14.2 million; the TTM figure through Mar 2026 stood at $14.2 million (down 75.76% YoY), while the FY2025 annual figure was $60.9 million, down 11.6% from the prior year.
- Cash & Current Investments eased to $14.2 million in Q1 2026 per KIDS's latest filing, from $60.9 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $118.3 million in Q4 2022 and bottomed at $11.3 million in Q2 2023.
- Historically, Cash & Current Investments has averaged $52.8 million across 5 years, with a median of $53.0 million in 2024.
- Annual changes were most pronounced in 2022 — Cash & Current Investments surged 999.84% — and 2023, when it tumbled 85.56%.
- Orthopediatrics' Cash & Current Investments stood at $118.3 million in 2022, then plunged by 72.08% to $33.0 million in 2023, then surged by 108.41% to $68.8 million in 2024, then declined by 11.6% to $60.9 million in 2025, then plunged by 76.59% to $14.2 million in 2026.
- Business Quant data shows KIDS's Cash & Current Investments at $14.2 million in Q1 2026, $60.9 million in Q4 2025, and $57.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Orthopediatrics | 631.76 Mn | 585.88 Mn | 52.37 Mn | 45.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 45.88 Mn |
| Mar 31, 2026 | 14.25 Mn |
| Dec 31, 2025 | 60.85 Mn |
| Sep 30, 2025 | 57.73 Mn |
| Jun 30, 2025 | 70.15 Mn |
| Mar 31, 2025 | 58.77 Mn |
| Dec 31, 2024 | 68.83 Mn |
| Sep 30, 2024 | 53.05 Mn |
| Jun 30, 2024 | 28.93 Mn |
| Mar 31, 2024 | 47.74 Mn |
| Dec 31, 2023 | 33.03 Mn |
| Sep 30, 2023 | 12.23 Mn |
| Jun 30, 2023 | 11.31 Mn |
| Mar 31, 2023 | 107.73 Mn |
| Dec 31, 2022 | 118.29 Mn |
| Sep 30, 2022 | 84.71 Mn |
| Jun 30, 2022 | 51.16 Mn |
| Mar 31, 2022 | 19.32 Mn |
| Dec 31, 2021 | 53.54 Mn |
| Sep 30, 2021 | 7.70 Mn |